Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Meeting Updates
We would like to inform you that the 32nd Annual General Meeting ('AGM') of the Company is scheduled to be held on Tuesday, September 24, 2019 at 09:00 A.M. at Ramee Guest Line Hotel - Dadar Plot No. 3, Kohinoor Road, Dadar, Mumbai - 400 014. Fredun Pharmaceuticals Ltd - 539730 - Shareholding for the Period Ended June 30, 2019
Fredun Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here Fredun Pharmaceuticals Ltd - 539730 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In compliance to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018; we furnish hereunder the confirmation certificate received from the SEBI Registered Share Transfer Agent viz. Purva Sharegistry (India) Pvt. Ltd. for the quarter ended June 30, 2019. Fredun Pharmaceuticals Ltd - 539730 - Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Priyanka ChaturvediDesignation :- Company Secretary and Compliance Officer Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading Window
The trading window for dealing in the securities of the Company will remain closed for designated persons and their immediate relatives with immediate effect till 48 hours after the end of the Board Meeting wherein; the approval of Un-Audited Financial Results for the quarter ended June 30, 2019; would be considered and approved. Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading Window
The trading window for dealing in the securities of the Company will remain closed for designated persons and their immediate relatives with immediate effect till 48 hours after the end of the Board Meeting wherein; the approval of Un-Audited Financial Results for the quarter ended June 30, 2019; would be considered and approved. Fredun Pharmaceuticals Ltd - 539730 - RECEIPT OF AWARD
We are happy to share with our stakeholders that the Company has received a Prestigious and a well-recognized award in the Pharma Sector 'Best Healthcare Brands of 2019' at Economic Times Best Healthcare Brands, 2019 presented to the Company on Wednesdav, June 26, 2019. Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We enclose herewith the copies of the Newspaper cuttings of the Financials Results of the Company for the Year ended March 2019; as approved by the Board in its Meeting held on Monday, June 10, 2019; published in Business Standard & Mumbai Lakshadeep newspaper(s) on June 14, 2019. Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find enclosed herewith the Corporate Presentation of the Company for the shareholders perusal. Fredun Pharmaceuticals Ltd - 539730 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Daulat Medhora